≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

All dysplastic lesions of the vulva

Endpoint Browser PheWeb

N14_VULVAL_DYSPLASIA_ALL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

1609

4. Check minimum number of events

None

1609

5. Include endpoints

None

1609

6. Filter based on genotype QC (FinnGen only)

1609

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9508 9508 -
Only index persons 8975 8975 -
Unadjusted period prevalence (%)
Whole population 0.27 0.27 -
Only index persons 0.33 0.33 -
Median age at first event (years)
Whole population - 38.96 -
Only index persons - 38.45 -

-FinnGen-

Key figures

All Female Male
Number of individuals 1609 1609 -
Unadjusted period prevalence (%) 0.55 0.55 -
Median age at first event (years) 40.58 40.58 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1414
Matched controls
14141
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
50.4
323.0
534
168
N90.0
ICD-10 Finland
Mild vulvar dysplasia
+∞
323.0
380
*
ULA02
NOMESCO Finland
Kolposcopy
12.0
323.0
739
1182
0781C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]
+∞
323.0
587
*
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
+∞
287.6
266
*
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
+∞
254.0
236
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
6.1
176.0
593
1489
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
47.5
170.2
208
51
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
154.4
168.6
176
13
8325
FHL
Coagulation, cryo or laser in anesthesia or operating room
266.8
143.0
144
6
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
140.0
132
*
LFC00
NOMESCO Finland
Partial excision of vulva
218.3
117.5
120
6
LEB00
NOMESCO Finland
Biopsy of vagina
15.3
116.7
200
151
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
112.0
106
*
8411
FHL
Local change laser, coagulation, biopsy or removal
146.0
102.6
108
8
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
46.0
102.5
126
30
A63.0
ICD-10 Finland
Anogenital (venereal) warts
9.2
92.6
204
253
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.3
91.7
318
740
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.2
88.7
398
1202
D06BB10
ATC
imiquimod; topical
8.1
81.8
195
273
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
9.0
76.4
170
212
N89.0
ICD-10 Finland
Mild vaginal dysplasia
39.8
57.2
72
19
D06BB04
ATC
podophyllotoxin; topical
5.5
56.7
180
366
LDA10
NOMESCO Finland
Curettage of cervix uteri
4.6
48.9
184
447
8326
FHL
Batch conization
22.6
47.4
69
32
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
47.0
686
4119
D07AD01
ATC
clobetasol; topical
2.9
46.2
341
1412
N87.0
ICD-10 Finland
Mild cervical dysplasia
5.9
44.2
130
239
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
41.9
40
*
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
45.1
39.3
48
11
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
20.4
38.1
57
29
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
4.0
38.0
164
451
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
15.1
34.7
58
40
J02AC01
ATC
fluconazole; systemic
1.9
30.3
825
5970
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
308.7
29.9
30
*
N90.4
ICD-10 Finland
Leukoplakia of vulva
16.7
29.5
47
29
1390
FHL
Colposcopy
67.4
29.0
33
5
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
105.6
28.8
31
*
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
102.1
27.7
30
*
6221A
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI LEVIS]
29.9
26.4
35
12
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
10.3
25.9
51
51
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
24.0
23
*
P01AB01
ATC
metronidazole; oral, rectal
1.8
24.0
695
4968
8111
FHL
Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)
27.2
23.6
32
12
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
37.0
23.0
29
8
N87.1
ICD-10 Finland
Moderate cervical dysplasia
4.3
22.9
87
212
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
4.2
21.3
82
202
6221B
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]
21.9
19.5
28
13
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
22.9
19.1
27
12
WX002
NOMESCO Finland
Sedation and analgesia
2.0
19.0
284
1592
N76.6
ICD-10 Finland
Ulceration of vulva
9.3
18.9
39
43
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
192.4
18.6
19
*
G01AA10
ATC
clindamycin; vaginal
1.8
18.3
354
2170
J01MA02
ATC
ciprofloxacin; systemic
1.7
17.9
507
3496
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
17.8
180
850
8113
FHL
Fractional scraping
2.6
17.7
135
551
N02AX02
ATC
tramadol; systemic, rectal
1.6
17.0
570
4108
G01AF01
ATC
metronidazole; vaginal
2.0
16.8
248
1376
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
5.0
16.6
53
109
7950A
ICD-9 Finland
Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix
30.4
16.1
21
7
A02BC02
ATC
pantoprazole; systemic
1.6
15.6
913
7528
WX320
NOMESCO Finland
Spinalanesthesy
1.8
15.6
319
1977
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
5.5
15.3
45
84
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
15.3
396
2640
127
Kela drug reimbursment
Transplant complication
7.4
15.0
35
48
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
14.8
222
1233
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.7
14.8
104
405
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
80.9
14.6
16
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.2
14.6
150
714
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.2
14.4
54
131
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.6
14.1
64
185
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
14.0
641
4923
8339
FHL
Other measure in this category
12.2
13.6
24
20
L04AA06
ATC
mycophenolic acid; systemic
5.4
13.5
40
76
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
4.7
13.5
45
98
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
2.2
13.2
135
638
J01FF01
ATC
clindamycin; systemic
1.6
13.1
380
2590
N03AX16
ATC
pregabalin; oral
1.7
13.1
344
2282
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
13.1
511
3762
8112
FHL
Scraping the cervix
50.5
12.9
15
*
Z3231
NOMESCO Finland
Registered nurse
1.6
12.7
354
2387
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
3.3
12.7
64
201
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
70.5
12.6
14
*
Z2221
NOMESCO Finland
Medical doctor
1.6
12.6
404
2827
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
+∞
12.5
12
*
ZXC10
NOMESCO Finland
Use of laser
4.4
12.5
45
106
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
12.4
360
2453
T89
ICPC
Diabetes insulin dependent
3.3
12.3
62
195
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
12.2
268
1686
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.1
12.1
67
225
L29.2
ICD-10 Finland
Pruritus vulvae
4.4
12.1
43
100
ZXC00
NOMESCO Finland
Use of diathermy
8.3
12.1
26
32
6221C
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]
18.2
12.1
18
10
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
12.0
331
2221
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
11.9
521
3917
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
11.8
141
713
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.7
11.7
23
24
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
11.7
422
3028
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
11.7
262
1657
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
11.7
452
3298
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.0
11.7
166
900
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
65.5
11.6
13
*
7020X
ICD-9 Finland
Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]
+∞
11.5
11
*
D07AC01
ATC
betamethasone; topical
1.5
11.4
456
3353
A10AA01
ATC
NA
3.6
11.2
49
138
E0000UV
ATC
NA
1.5
11.1
554
4266
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
11.0
392
2799
ZXE00
NOMESCO Finland
One hour or less
1.5
10.8
546
4210
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
5.0
10.7
33
67
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
10.6
483
3639
B01AB10
ATC
tinzaparin; parenteral
2.3
10.5
100
460
ZXA00
NOMESCO Finland
Right side
1.6
10.5
338
2352
LFD00
NOMESCO Finland
Vulvectomy
110.8
10.4
11
*
C03CA01
ATC
furosemide; systemic
1.6
10.4
279
1848
A10AE04
ATC
insulin glargine; parenteral
2.2
10.4
100
463
A10AA02
ATC
NA
3.1
10.3
54
176
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.1
10.2
54
178
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
10.2
340
2383
R4110
NOMESCO Finland
Physiotherapy
1.6
10.1
338
2370
J01EA01
ATC
trimethoprim; systemic
1.5
10.0
418
3081
UKC02
NOMESCO Finland
Cystoscopy
1.9
10.0
145
793
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
9.9
359
2563
G01AF04
ATC
miconazole; vaginal
2.0
9.9
123
636
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
20.2
9.8
14
7
N02BE01
ATC
paracetamol; systemic, rectal
1.6
9.7
1199
10988
J01DB01
ATC
cefalexin; oral
1.5
9.7
1134
10254
UJF32
NOMESCO Finland
Coloscopy
1.5
9.6
328
2306
TLC02
NOMESCO Finland
Simple extraction of IUD
2.2
9.5
100
480
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
100.7
9.4
10
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.7
9.4
63
240
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
21.8
9.4
13
6
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.4
9.2
32
74
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.5
9.2
31
70
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
9.2
215
1370
TAC99
NOMESCO Finland
Other blockade for chronic pain
5.9
9.1
24
41
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
9.0
796
6750
LFE10
NOMESCO Finland
Plastic repair of vulva
9.1
9.0
18
20
J05AB11
ATC
valaciclovir; oral
1.7
9.0
195
1214
Z94.0
ICD-10 Finland
Kidney transplant status
6.6
9.0
22
34
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
8.9
124
669
H04AA01
ATC
glucagon; nasal, parenteral
3.6
8.9
38
107
N06AB06
ATC
sertraline; oral
1.8
8.9
168
1006
J01MA12
ATC
levofloxacin; systemic
1.7
8.7
208
1335
R2110
NOMESCO Finland
Giving the first information
1.9
8.7
126
690
LFC96
NOMESCO Finland
Other partial excision of vulva or perineum
50.3
8.7
10
*
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
50.3
8.7
10
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
8.7
347
2520
ZXD05
NOMESCO Finland
Urgent procedure
1.5
8.7
395
2953
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.3
8.6
25
48
J05AB01
ATC
aciclovir; systemic
1.5
8.6
315
2243
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
8.6
196
1240
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
8.6
459
3539
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
8.6
87
413
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
16.4
8.6
13
8
N94.1
ICD-10 Finland
Dyspareunia
4.4
8.4
29
67
WX110
NOMESCO Finland
Local anesthesy
1.4
8.4
940
8267
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
8.4
157
937
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
6.7
8.4
20
30
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
+∞
8.3
8
*
J02AC02
ATC
itraconazole; systemic
1.5
8.3
273
1896
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.3
893
7788
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
5.5
8.3
23
42
N01BB02
ATC
lidocaine; parenteral
4.8
8.3
26
55
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
8.2
292
2066
J01AA02
ATC
doxycycline; systemic
1.5
8.2
1101
9989
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
8.2
67
288
8513
FHL
Softening of cervix with abortifacient or laminars and associated surgical emptying of the uterus
2.5
8.2
63
262
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.2
47
164
H3603, E103
ICD-10 Finland
NA
5.7
8.1
22
39
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
8.1
104
545
ZX120
NOMESCO Finland
Intravenous
1.9
8.1
123
684
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
8.0
103
539
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
8.0
53
203
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
8.0
168
1036
A11CC03
ATC
alfacalcidol; systemic
3.6
8.0
34
96
L04AX01
ATC
azathioprine; systemic
2.4
7.9
67
292
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
13.1
7.9
13
10
N81.6
ICD-10 Finland
Rectocele
1.9
7.8
119
662
M03BX02
ATC
tizanidine; oral
1.4
7.8
903
7925
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.8
7.8
140
827
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.7
521
4172
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
5.1
7.7
23
46
M54.5
ICD-10 Finland
Low back pain
1.4
7.7
456
3567
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
7.7
712
6016
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
6.0
7.7
20
34
ZXA10
NOMESCO Finland
Bilateral
1.6
7.7
231
1568
M01AE02
ATC
naproxen; oral, rectal
1.4
7.6
785
6746
A02BC05
ATC
esomeprazole; systemic
1.4
7.6
548
4436
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
11.9
7.6
13
11
C539, 6666, 0
ICD-O-3
NA
3.8
7.6
30
80
09992
ICD-8 Finland
Other veneral disease, Condyloma acuminatum
10.1
7.5
14
14
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
7.5
101
538
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
7.5
508
4072
M79.6
ICD-10 Finland
Pain in limb
1.4
7.5
501
4004
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.4
7.4
34
102
N06AB04
ATC
citalopram; systemic
1.5
7.4
309
2256
H02AB06
ATC
prednisolone; systemic
1.4
7.4
605
4995
L04AA01
ATC
[U] ciclosporin; systemic
3.8
7.4
29
77
SPAT1262
SPAT
Handing over of treatment supplies
1.6
7.3
181
1170
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
8.4
7.3
15
18
K05.31
ICD-10 Finland
Periodontitis pronounced
1.9
7.3
105
574
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
7.3
231
1588
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
7.2
123
713
A02BC03
ATC
lansoprazole; oral
1.4
7.2
379
2892
E000006
ATC
NA
1.9
7.2
108
599
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
7.2
197
1308
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
7.1
117
671
N30.0
ICD-10 Finland
Acute cystitis
1.6
7.1
215
1460
8511
FHL
Cervical dilation and drainage with suction
2.0
7.1
84
428
A02BX02
ATC
sucralfate; oral
2.5
7.1
54
225
N05BA04
ATC
oxazepam; oral
1.4
7.1
338
2534
J01CA08
ATC
pivmecillinam; oral
1.3
7.1
725
6193
LEB10
NOMESCO Finland
Excision of lesion of vagina
5.6
7.1
19
34
Z01.2
ICD-10 Finland
Dental examination
1.4
7.1
566
4650
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.2
7.0
25
61
R06AE07
ATC
cetirizine; oral
1.4
7.0
629
5260
A10AE05
ATC
insulin detemir; parenteral
2.2
7.0
64
292
H3600, E103
ICD-10 Finland
NA
4.5
7.0
23
52
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
5.5
6.9
19
35
M01AB05
ATC
diclofenac; systemic, rectal
1.4
6.9
915
8121
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.9
917
8148
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.8
208
1416
L57.0
ICD-10 Finland
Actinic keratosis
1.9
6.8
97
531
K59.0
ICD-10 Finland
Constipation
2.1
6.8
70
338
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.7
95
519
G44.2
ICD-10 Finland
Tension-type headache
1.6
6.7
203
1379
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
6.7
143
890
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.5
6.6
50
208
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
6.6
238
1686
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.7
6.5
129
785
ZXA05
NOMESCO Finland
Left side
1.4
6.5
304
2263
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
6.9
6.5
15
22
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
6.5
120
716
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
6.2
6.5
16
26
B02AA02
ATC
tranexamic acid; systemic
1.5
6.4
271
1977
N03AX12
ATC
gabapentin; oral
1.5
6.4
206
1416
6230A
ICD-9 Finland
Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE LEVIS]
70.1
6.4
7
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
6.4
67
324
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
6.4
174
1153
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.3
753
6533
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
6.3
138
862
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
6.3
108
628
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
6.3
86
464
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
3.9
6.3
24
63
ZZR00
NOMESCO Finland
Flap of skin
3.1
6.3
31
100
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
18.1
6.3
9
5
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
6.2
160
1046
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
5.8
6.1
16
28
J01FA06
ATC
roxithromycin; oral
1.3
6.1
557
4637
R03AC02
ATC
salbutamol; inhalant
1.3
6.1
730
6327
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
12.6
6.1
10
8
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
2.1
6.1
67
331
R06.0
ICD-10 Finland
Dyspnoea
1.4
6.1
292
2185
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
6.0
225
1598
LFW96
NOMESCO Finland
Other operation on vulva or perineum
10.1
6.0
11
11
6160A
ICD-9 Finland
Inflammatory disease of cervix, vagina and vulva, Cervicitis and endocervicitis
10.1
6.0
11
11
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
6.0
173
1160
N06AX16
ATC
venlafaxine; oral
1.5
6.0
200
1388
N06AX11
ATC
mirtazapine; oral
1.4
6.0
418
3335
C07AA05
ATC
propranolol; systemic
1.4
6.0
281
2093

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
279
296
11.19
243.34
2.9
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
98
78
13.31
101.59
2.8
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
265
841
3.58
69.46
2.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
684
3766
2.42
62.70
2.3
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
960
6238
2.34
58.59
3.9
2.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
40
40
10.23
35.47
1.7
1.8
ug/l
8.5
2.0
0.49
25
20
(4035726)
263
1225
2.37
32.39
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
324
1815
1.98
24.38
1.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
272
1449
2.06
23.49
2.3
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
605
4195
1.71
22.33
2.8
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
536
3643
1.71
21.01
4.4
2.9
e6/l
40.4
73.2
0.74
421
2712
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
318
1864
1.88
20.57
3.5
2.6
e6/l
4.4
4.6
0.16
190
915
(3020779) Urea [Moles/volume] in Serum or Plasma
173
814
2.26
20.39
11.7
6.7
mmol/l
8.5
8.2
0.27
165
779
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
478
3183
1.71
20.01
2.5
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
747
5588
1.63
19.87
6.5
4.1
g/l
35.7
36.2
1.63
715
5200
(3018095) Leukocytes [#/volume] in Urine
626
4490
1.65
19.66
5.1
3.4
e6/l
71.8
91.9
0.58
464
2988
(42870588) Differential panel, method unspecified - Blood
626
4495
1.64
19.54
7.4
5.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
321
1939
1.82
18.70
4.0
3.0
mmol/l
0.8
0.8
2.16
308
1807
(3031040) Bacteria [#/volume] in Urine by Automated count
1088
9034
1.63
18.03
5.9
4.4
e6/l
108.6
2215.1
—
7
111
(36304419) Bacteria [Presence] in Urine
486
3335
1.66
17.78
4.2
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
485
3357
1.64
17.01
4.3
2.8
e6/l
0.2
0.4
2.28
376
2457
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
808
6316
1.56
16.81
4.6
3.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
759
5854
1.56
16.73
7.3
5.0
mmol/l
1.2
1.2
0.84
695
5308
(3003458) Phosphate [Moles/volume] in Serum or Plasma
250
1448
1.86
16.52
9.6
4.4
mmol/l
1.1
1.0
1.11
235
1324
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
323
2031
1.74
16.18
3.2
2.5
e6/l
1.3
1.2
0.02
194
1079
(3042936) Bacteria identified in Isolate by Culture
279
1684
1.79
16.09
2.5
1.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
211
3.17
16.04
6.8
4.8
iu/ml
416.4
296.4
0.22
16
22
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
866
6930
1.54
15.83
6.9
5.6
umol/l
9.2
10.0
3.04
838
6566
(3033658) Prothrombin time (PT) actual/Normal
475
3325
1.61
15.68
5.2
3.3
%
97.4
96.9
0.18
463
3221
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
208
1164
1.90
15.24
2.6
2.0
g/l
0.2
0.2
0.18
201
1101
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
566
4154
1.56
15.14
3.0
2.3
u/l
53.3
55.5
0.95
536
3826
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
819
6517
1.52
15.07
8.2
5.7
mmol/l
1.2
1.2
1.87
718
5506
(3026782) Osmolality of Urine
353
2320
1.67
14.89
4.1
2.5
mosm/kgh2o
487.0
514.3
1.63
312
1969
(3037467) Urinalysis macro (dipstick) panel - Urine
1106
9412
1.56
14.73
5.8
4.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
507
3649
1.57
14.69
4.5
3.0
mmol/l
6.3
6.7
1.61
421
3104
(3026008) Bacteria identified in Urine by Culture
580
4309
1.54
14.54
3.5
3.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
77
292
2.72
14.42
3.3
2.8
mg/l
1.6
1.4
1.32
72
272
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1207
10512
1.59
14.22
9.5
7.0
u/l
76.3
76.2
0.06
1146
9890
(3013650) Neutrophils [#/volume] in Blood by Automated count
969
8068
1.51
13.82
11.4
8.7
e9/l
3.9
3.9
0.08
870
7088
(40758558) Short blood count panel - Blood
497
3613
1.54
13.56
9.0
6.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
368
2525
1.59
12.83
3.7
2.4
e6/l
7.2
8.1
0.44
320
2214
(3012516) Albumin [Mass/volume] in Urine
468
3392
1.54
12.81
4.3
3.1
mg/l
191.8
434.2
0.95
301
1951
(3001604) Monocytes [#/volume] in Blood
844
6909
1.47
12.57
7.9
5.5
e9/l
0.6
0.5
1.12
764
6024
(3019198) Lymphocytes [#/volume] in Blood
865
7115
1.47
12.56
7.9
5.6
e9/l
1.9
2.0
0.83
801
6327
(3013115) Eosinophils [#/volume] in Blood
874
7206
1.47
12.52
8.1
5.7
e9/l
0.2
0.2
0.93
808
6366
(3006315) Basophils [#/volume] in Blood
845
6935
1.46
12.31
7.9
5.5
e9/l
0.0
0.0
0.33
765
6037
(3009261) Glucose [Presence] in Urine by Test strip
836
6857
1.46
12.16
4.5
3.7
estimate
0.0
0.0
1.32
131
1223
(3021601) Nitrite [Presence] in Urine by Test strip
829
6796
1.45
12.05
5.9
5.0
estimate
0.0
0.0
0.50
134
1226
(3023368) Bacteria identified in Blood by Culture
405
2881
1.54
11.94
5.1
3.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
158
876
1.89
11.84
2.0
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
36
5.90
11.81
2.8
2.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
672
5314
1.45
11.71
2.1
1.9
pmol/l
100.1
98.7
0.27
341
2617
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
257
1652
1.66
11.57
2.0
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
814
6689
1.44
11.45
7.9
5.7
%
28.4
29.2
1.27
763
6240
(3020682) Albumin/Creatinine [Ratio] in Urine
478
3549
1.49
11.43
5.2
3.8
mg/mmol
12.8
7.5
1.18
308
2073
(3019069) Monocytes/100 leukocytes in Blood
793
6496
1.44
11.28
8.1
5.9
%
8.2
8.1
0.30
743
6091
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
420
3047
1.51
11.20
2.9
2.8
ng/l
901.0
866.8
0.09
357
2542
(3013707) Erythrocyte sedimentation rate by Westergren method
1188
10507
1.50
11.18
5.1
4.1
mm/h
12.6
11.7
1.49
1119
9772
(40768797) Stomach Pathology biopsy report
300
2023
1.59
11.10
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
11
10.98
11.07
4.2
7.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
803
6609
1.43
11.04
7.7
5.5
%
57.1
56.6
0.67
755
6182
(3013826) Glucose [Moles/volume] in Serum or Plasma
881
7375
1.43
11.01
5.7
4.0
mmol/l
6.7
6.5
1.38
832
6850
(3006504) Eosinophils/100 leukocytes in Blood
786
6458
1.42
10.83
7.9
5.6
%
2.9
2.8
0.79
735
6012
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
232
1486
1.66
10.54
2.9
2.3
umol/l
5.8
6.2
0.20
202
1275
(3017143) Hepatitis C virus Ab [Presence] in Serum
234
1505
1.65
10.46
1.7
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
243
1583
1.63
10.32
3.9
2.3
%
21.5
22.5
0.61
212
1362
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
229
1476
1.64
10.13
1.9
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
114
597
1.98
10.11
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
284
1934
1.57
9.99
3.5
2.2
umol/l
12.9
13.4
0.63
263
1787
(3000991) Gas panel - Venous blood
146
833
1.83
9.99
9.0
7.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
758
6246
1.40
9.97
8.0
5.7
%
0.7
0.7
0.58
709
5813
(3004789) Transferrin [Mass/volume] in Serum or Plasma
261
1745
1.59
9.94
3.6
2.2
g/l
2.3
2.4
3.14
238
1615
(3021960) Folate [Moles/volume] in Serum or Plasma
392
2879
1.48
9.64
1.6
1.5
nmol/l
23.3
21.7
0.54
351
2494
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
759
6281
1.39
9.61
2.7
2.3
nmol/l
79.3
78.3
0.44
681
5718
(3025941) Bacteria identified in Stool by Culture
148
860
1.79
9.53
1.4
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1478
13880
1.80
9.46
18.8
12.1
mg/l
19.5
19.8
0.14
1221
10771
(3035350) Ketones [Presence] in Urine by Test strip
805
6739
1.39
9.46
4.5
3.6
estimate
0.0
0.0
0.00
127
1219
(3018418) pH of Serum or Plasma
507
3924
1.43
9.41
5.8
3.5
ph
7.4
7.4
0.23
77
720
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
189
1181
1.68
9.41
4.8
4.5
u/l
230.2
249.2
1.12
182
1116
(3007164) IgA [Mass/volume] in Serum or Plasma
400
2979
1.46
9.09
1.5
1.4
g/l
2.1
2.2
0.83
228
1817
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
113
613
1.91
9.06
4.4
3.1
kpa
5.1
5.2
1.10
105
573
(3009343) pH of Capillary blood
111
608
1.89
8.65
4.4
3.0
ph
7.4
7.4
0.02
16
78
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
588
1.90
8.57
4.3
3.0
mmol/l
1.4
1.8
0.60
86
453
(3019309) Folate [Moles/volume] in Red Blood Cells
311
2236
1.48
8.39
1.8
1.7
nmol/l
1198.2
1204.5
0.04
253
1675
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
309
2.22
8.33
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
206
1356
1.60
8.32
18.7
19.8
inr
1.3
1.2
0.13
25
198
(3032080) INR in Blood by Coagulation assay
571
4587
1.38
8.30
9.5
7.2
inr
1.2
1.1
0.22
147
1397
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
222
1489
1.57
8.27
1.7
1.6
%
1.4
1.3
0.53
193
1333
(3021447) Carbon dioxide [Partial pressure] in Venous blood
154
944
1.70
8.23
5.7
3.0
kpa
5.9
5.8
0.10
148
917
(3011397) Hemoglobin [Presence] in Urine by Test strip
414
3153
1.42
8.22
4.4
3.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
161
999
1.68
8.22
3.3
2.8
g/l
10.2
10.4
0.26
149
914
(3002032) Base excess in Venous blood by calculation
152
931
1.70
8.14
5.7
3.0
mmol/l
2.1
2.1
0.05
125
762
(3037522) Nuclear Ab [Titer] in Serum
303
2186
1.48
8.01
1.5
1.4
titre
645.3
581.4
0.24
76
470
(3000570) Elastase.pancreatic [Mass/mass] in Stool
81
409
2.03
8.00
1.4
1.4
ug/g
344.3
308.0
0.67
49
229
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
85
439
1.99
7.89
2.5
1.9
g/l
1.6
1.5
0.16
71
383
(3018677) aPTT in Platelet poor plasma by Coagulation assay
247
1714
1.52
7.88
2.6
1.9
s
28.7
29.3
1.29
241
1656
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
484
3820
1.38
7.72
2.3
2.1
u/l
116.5
159.4
1.50
461
3604
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
89
472
1.94
7.66
6.4
3.2
mmol/l
24.2
24.4
0.24
81
428
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
12
18
6.71
7.61
1.2
1.1
ng/l
23.4
47.7
—
5
12
(3014765) Yersinia sp identified in Stool by Organism specific culture
86
455
1.94
7.46
1.2
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
161
1035
1.62
7.16
5.1
3.1
ng/l
102.3
74.5
2.18
143
896
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1398
13105
1.51
7.11
16.0
10.9
ml/min/173m2
83.1
83.8
0.58
1200
10825
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
52
231
2.29
7.11
1.6
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
76
394
1.97
7.01
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
131
804
1.69
6.98
1.6
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
305
2258
1.43
6.97
3.9
3.3
ng/l
88.4
300.4
3.06
201
1522
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
329
2472
1.42
6.92
3.0
2.8
mmol/l
2.4
2.4
0.02
276
2174
(42529406) Shigella sp [Presence] in Stool by Culture
85
460
1.90
6.91
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
228
1601
1.49
6.84
1.6
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
419
3289
1.37
6.77
2.5
2.2
mg/l
3.1
2.9
0.64
371
2803
(3028026) IgM [Mass/volume] in Serum or Plasma
127
780
1.68
6.75
1.8
1.8
g/l
1.3
1.4
0.16
115
713
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
48
211
2.31
6.74
1.6
1.3
u/ml
109.2
121.6
—
9
40
(3015235) Bicarbonate [Moles/volume] in Capillary blood
52
237
2.23
6.71
3.8
2.6
mmol/l
24.4
25.3
0.78
43
211
(3024354) Oxygen [Partial pressure] in Venous blood
125
766
1.69
6.70
4.6
2.5
kpa
4.9
4.6
0.65
116
741
(3022689) Creatine [Moles/volume] in Urine
15
32
4.72
6.69
1.5
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
53
244
2.21
6.68
1.5
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
83
451
1.89
6.68
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1477
14052
1.62
6.62
20.0
13.0
mmol/l
139.5
139.7
2.01
1455
13710
(4015189)
12
21
5.75
6.59
1.8
3.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
577
4777
1.32
6.49
4.1
3.3
mmol/l
2.4
2.4
0.29
505
4230
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
168
1119
1.56
6.43
3.0
3.3
pmol/l
4.3
4.5
0.72
142
993
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
557
4594
1.32
6.42
4.0
2.8
u/l
32.8
30.4
0.38
535
4395
(3036481) Cortisol [Moles/volume] in Serum or Plasma
199
1379
1.51
6.36
2.1
2.0
nmol/l
373.3
373.7
0.01
183
1262
(3026389) Candida sp identified in Specimen by Organism specific culture
46
204
2.29
6.35
1.6
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
149
971
1.59
6.27
1.4
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1478
14091
1.60
6.23
20.4
13.1
mmol/l
3.9
3.9
0.53
1456
13711
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
157
1038
1.57
6.21
1.7
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
261
1924
1.43
6.06
2.0
2.2
ug/g
168.3
103.7
1.13
197
1509
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
251
1838
1.43
6.04
2.1
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1421
13448
1.48
6.03
6.1
5.3
mu/l
1.8
2.1
1.13
1332
12545
(40768446) Kidney Pathology biopsy report
15
35
4.32
6.03
1.8
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
49
229
2.18
5.98
1.8
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
108
660
1.68
5.88
1.7
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
69
3.22
5.88
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
174
1195
1.51
5.80
3.1
2.5
%
1.9
1.8
0.17
155
1053
(3052851) Hemolysis interference index of Serum or Plasma
72
392
1.88
5.79
5.5
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
408
3260
1.34
5.75
1.9
1.7
mg/l
1.0
0.9
0.37
315
2440
(3037121) Protein [Mass/volume] in Urine
71
387
1.87
5.70
2.9
2.9
g/l
0.4
0.3
0.29
33
125
(3019150) Specific gravity of Urine by Refractometry
366
2881
1.35
5.69
4.7
4.1
kg/l
1.0
1.0
1.02
58
413
(3001122) Ferritin [Mass/volume] in Serum or Plasma
769
6699
1.28
5.68
3.5
2.8
ug/l
100.5
82.4
1.89
723
6279
(3026493) Urate [Moles/volume] in Serum or Plasma
413
3312
1.33
5.67
2.8
2.2
umol/l
2940.6
4181.4
0.34
362
2882
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
76
3.06
5.65
2.4
2.6
e6/l
663.6
733.9
—
8
33
(3003327) Ova and parasites identified in Stool by Light microscopy
88
517
1.74
5.54
1.4
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1514
14568
1.67
5.53
16.4
11.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
78
445
1.79
5.43
4.7
3.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
29
112
2.62
5.40
2.3
2.4
e9/l
1.2
1.2
0.03
19
71
(46235355) HIV 1 and 2 tests - Meaningful Use set
312
2419
1.36
5.33
2.0
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1529
14764
1.72
5.32
13.2
9.8
u/l
23.8
23.9
0.18
1492
14326
(3013512) EKG study
441
3597
1.31
5.32
3.9
3.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1274
11896
1.34
5.31
5.1
4.5
pmol/l
14.8
14.6
1.45
1191
11048
(3004716) Salmonella sp identified in Stool by Organism specific culture
132
874
1.56
5.21
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
50
250
2.03
5.17
1.3
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
138
925
1.54
5.16
7.1
5.7
mmol/l
1.2
1.3
0.77
130
891
(3023520) Reticulocytes [#/volume] in Blood
130
860
1.56
5.16
2.6
2.6
e9/l
69.9
73.9
0.64
98
633
(3023183) Ammonium ion [Moles/volume] in Plasma
41
190
2.19
5.15
2.0
2.4
umol/l
30.1
33.6
0.43
35
166
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
177
1250
1.47
5.15
2.5
2.2
u/l
30.8
35.6
1.08
149
1065
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
87
521
1.71
5.13
3.3
2.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
130
861
1.55
5.13
2.4
2.9
ng/l
213.6
157.6
0.63
115
770
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
156
1077
1.50
5.08
2.2
2.3
ml/min/173m2
60.7
70.9
1.84
54
422
(3045414) Leukocytes [Presence] in Urine
104
656
1.63
5.04
2.2
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
543
4582
1.28
5.00
3.8
3.1
ng/l
20.0
35.4
0.95
327
2623
(3051651) Icteric interference index of Serum or Plasma
21
71
2.98
4.99
6.1
3.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
88
2.75
4.95
1.8
1.9
%
13.0
12.0
0.13
14
35
(3022145) Colonoscopy Study observation
212
1562
1.41
4.91
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1033
9430
1.27
4.82
3.5
2.9
u/l
45.8
39.6
1.53
985
8874
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
62
3.09
4.80
2.2
2.7
%
32.6
47.4
—
5
20
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
607
5213
1.26
4.78
4.7
3.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
46
230
2.03
4.78
1.4
1.2
u/ml
327.0
269.2
0.65
34
143
(1175426) CD3 cells/100 lymphocytes in Blood
24
90
2.69
4.75
1.8
1.9
%
73.4
73.5
0.02
24
84
(3021901) Oxygen saturation in Capillary blood
36
164
2.22
4.74
4.0
2.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
697
6093
1.25
4.69
11.6
8.4
e9/l
0.0
0.0
0.00
601
4970
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
431
3556
1.29
4.69
1.3
1.3
u/ml
1.9
1.5
0.16
110
945
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
264
2037
1.35
4.62
1.7
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
56
304
1.87
4.61
1.2
1.4
—
12.7
—
0
7
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
98
625
1.60
4.57
1.7
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
25
4.42
4.56
5.6
4.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
168
1203
1.44
4.56
6.4
6.7
mmol/l
0.9
1.3
0.62
132
938
(3027801) Oxygen [Partial pressure] in Arterial blood
168
1206
1.44
4.50
6.6
6.7
kpa
13.1
13.0
0.09
162
1148
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
168
1206
1.44
4.50
6.6
6.7
kpa
5.1
5.1
0.10
162
1149
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
87
2.67
4.49
2.0
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
131
2.31
4.37
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
80
492
1.66
4.32
1.3
1.3
u/ml
38.6
40.3
—
6
35
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
214
1614
1.38
4.32
4.4
4.2
%
32.9
33.2
0.11
150
1108
(3015171) Extractable nuclear Ab [Units/volume] in Serum
101
659
1.57
4.29
1.4
1.3
u/ml
0.5
1.0
0.46
13
56
(3000060) B lymphocytes [#/volume] in Blood
12
31
3.89
4.26
1.6
1.8
e6/l
230.0
156.1
—
7
18
(3016502) Oxygen saturation in Arterial blood
147
1042
1.45
4.22
6.8
7.2
%
95.8
96.1
0.23
141
1001
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
441
3692
1.27
4.20
1.7
1.6
mmol/l
1.4
1.4
0.48
386
3177
(3029937) Albumin [Presence] in Urine by Test strip
425
3545
1.27
4.17
5.1
4.0
estimate
0.0
0.0
1.08
135
1234
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
63
367
1.75
4.15
1.3
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
23
91
2.55
4.14
3.2
2.9
mg/l
374.3
25.3
0.55
13
58
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
73
446
1.67
4.06
1.3
1.3
u/ml
12.7
8.1
—
9
51
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
14
42
3.35
4.04
1.7
1.9
%
32.9
26.6
0.94
14
37
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
369
3037
1.28
4.02
1.6
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
33
156
2.14
4.01
1.8
2.0
mg/l
19.8
25.4
0.33
12
43
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
51
282
1.83
4.00
2.0
2.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
143
2.19
4.00
1.2
1.2
u/l
50.2
66.4
0.74
21
96
(3006184) Hemoglobin [Mass/volume] in Capillary blood
46
247
1.89
3.96
2.4
1.9
g/l
123.0
130.1
1.29
32
177
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
86
552
1.59
3.94
7.3
7.8
mmol/l
24.2
24.4
0.24
79
514
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
226
1.93
3.94
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
226
1.93
3.94
1.6
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
52
291
1.81
3.93
1.8
2.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
112
2.34
3.93
1.1
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
23
94
2.47
3.89
2.4
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
95
627
1.55
3.87
1.9
1.9
u/l
2271.9
3093.7
0.21
33
244
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
357
2940
1.28
3.86
1.4
1.3
iu/ml
24.7
29.0
0.45
94
944
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
49
3.08
3.81
1.7
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
73
455
1.63
3.78
1.3
1.3
u/ml
5.8
10.5
0.48
14
88
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
55
318
1.76
3.75
1.4
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
167
1239
1.39
3.74
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
168
1252
1.38
3.66
2.0
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
130
2.17
3.58
5.7
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
38
199
1.93
3.55
1.7
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
127
911
1.43
3.46
3.1
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
126
2.16
3.42
1.2
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
88
594
1.51
3.27
2.1
2.0
u/l
41.4
39.8
0.28
76
535
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1382
13264
1.30
3.27
4.2
3.7
mmol/l
1.3
1.2
2.18
1288
12313
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1313
12535
1.26
3.17
6.6
5.1
mmol/mol
39.8
38.8
3.08
1235
11713
(3000492) Spirometry study
173
1328
1.34
3.14
1.5
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
72
471
1.55
3.10
4.1
1.9
g/l
0.2
0.2
0.72
72
445
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
39
3.09
3.09
1.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
195
1.87
3.08
1.6
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
139
2.03
3.06
2.4
2.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
74
489
1.54
3.05
4.0
1.8
g/l
1.1
1.2
1.57
74
459
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
56
347
1.64
3.02
3.5
2.1
g/l
3.7
3.6
0.17
51
328
(3034426) Prothrombin time (PT)
13
45
2.90
3.02
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
16
63
2.56
2.96
3.1
3.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
62
397
1.58
2.94
1.6
1.6
—
370.0
—
0
20
(3017732) Neutrophils [#/volume] in Blood
137
1026
1.37
2.93
2.6
2.6
e9/l
4.3
4.1
0.48
108
830
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
59
374
1.60
2.92
2.2
2.1
mg/l
10.5
11.0
0.29
53
344
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
282
1.69
2.88
4.0
3.4
u/ml
0.3
0.4
0.38
28
155
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
22
102
2.17
2.87
1.1
1.2
titre
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
9
6.69
2.87
4.7
14.0
mmol/l
4.2
5.7
—
6
9
(3024731) MCV [Entitic volume]
1571
15445
1.73
2.87
26.8
18.1
fl
91.1
90.8
2.15
1557
15274
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
116
849
1.39
2.86
2.3
2.2
ug/l
3.6
5.5
1.56
104
732
(3035941) MCH [Entitic mass]
1571
15446
1.72
2.85
26.8
18.1
pg
30.2
30.1
1.61
1557
15274
(3026361) Erythrocytes [#/volume] in Blood
1571
15447
1.72
2.84
26.9
18.2
e12/l
4.4
4.4
3.79
1540
15086
(3024891) Influenza virus A+B Ag [Presence] in Specimen
59
377
1.59
2.83
1.2
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1571
15448
1.72
2.82
27.0
18.2
e9/l
6.7
6.6
0.98
1542
15084
(3004588) Protein electrophoresis panel - Serum or Plasma
109
793
1.40
2.79
1.4
2.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1570
15439
1.70
2.77
27.0
18.2
e9/l
267.0
266.7
0.08
1545
15114
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
30
159
1.90
2.76
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1014
9491
1.18
2.73
4.1
3.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1571
15455
1.70
2.71
27.1
18.3
g/l
131.7
132.7
2.27
1558
15281
(3020630) Protein [Mass/volume] in Serum or Plasma
125
936
1.36
2.70
1.6
2.6
g/l
65.0
67.2
1.84
108
859
(40761535) Cells panel - Urine sediment
134
1017
1.35
2.66
4.7
3.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
198
1.78
2.65
5.7
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
213
1.75
2.64
6.2
2.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
22
106
2.09
2.63
1.5
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
7
7.16
2.55
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
162
1273
1.30
2.53
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
196
1582
1.27
2.49
7.1
5.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
72
499
1.46
2.43
2.1
1.9
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
8
6.27
2.37
6.0
1.5
—
—
—
0
0
(4211845)
16
71
2.27
2.34
3.1
3.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
85
2.13
2.29
1.4
1.5
u/l
14.0
5.8
—
7
40
(3007566) Smooth muscle Ab [Titer] in Serum
56
374
1.52
2.27
1.3
1.2
titre
270.0
108.0
—
6
25
(3016879) Cocaine [Presence] in Urine
61
415
1.49
2.27
3.7
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
13
4.63
2.27
1.2
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
99
2.03
2.26
1.3
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
38
232
1.65
2.24
1.5
1.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
58
392
1.50
2.23
1.4
1.4
u/l
37.6
29.9
0.89
49
316
(3024471) HLA-A [Type]
9
29
3.12
2.22
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
72
1001
0.71
2.22
1.4
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
73
2.20
2.21
1.7
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
36
2.79
2.20
1.3
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
48
2.51
2.18
1.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
42
2.63
2.18
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
42
2.63
2.18
1.1
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1044
9883
1.16
2.16
3.4
3.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
101
1.99
2.16
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
220
1.65
2.13
1.2
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
76
547
1.41
2.13
9.4
9.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
109
1.94
2.11
1.2
1.0
—
—
—
0
0
(3019225) pH of Specimen
164
1326
1.26
2.08
4.1
3.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
89
661
1.37
2.08
5.5
5.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
45
293
1.55
2.07
4.2
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
238
1.61
2.05
3.3
2.5
ug/min
109.8
98.8
0.05
25
155
(1001926) Buprenorphine [Presence] in Urine by Screen method
52
353
1.49
1.99
4.2
1.5
—
—
—
0
0
(4034850)
62
436
1.44
1.99
10.7
7.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
53
362
1.48
1.97
1.4
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
338
1.49
1.96
2.6
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
327
2856
1.18
1.94
1.4
1.3
u/ml
8.0
10.8
0.39
122
1148
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
27
2.97
1.93
1.1
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
322
2811
1.18
1.92
1.7
1.6
pmol/l
488.5
28632555.9
2.47
273
2354
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
65
466
1.41
1.89
1.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
64
458
1.41
1.88
3.8
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
482
5315
0.87
1.88
2.9
2.6
—
—
—
0
0
(4010399)
123
974
1.28
1.87
1.4
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
15
72
2.09
1.86
2.9
2.6
e9/l
0.2
0.4
0.50
15
72
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
182
1.66
1.85
1.1
1.3
nmol/l
—
—
—
0
0
(4062490)
25
144
1.75
1.85
1.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
64
460
1.41
1.84
3.8
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
59
2.21
1.84
1.1
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
17
3.54
1.84
1.2
1.5
—
—
—
0
0
(4268621)
26
152
1.72
1.84
2.1
2.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
34
215
1.59
1.80
3.3
2.1
%
15.8
16.4
0.43
23
101
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
35
2.58
1.80
1.7
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
80
2.01
1.80
1.8
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
16
80
2.01
1.80
1.1
1.4
—
76.7
—
0
9
(3036489) Thrombin time
69
505
1.38
1.80
2.8
1.7
s
22.0
20.7
1.08
59
431
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
60
2.18
1.78
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
47
2.35
1.78
1.3
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
114
1428
0.78
1.76
1.7
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
154
1.70
1.76
1.6
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
18
3.34
1.74
1.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
30
2.67
1.72
1.1
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
30
2.67
1.72
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
226
1.56
1.71
1.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
75
2.01
1.69
1.7
1.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
16
82
1.96
1.69
1.1
1.4
—
903.3
—
0
9
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
30
187
1.62
1.69
1.3
1.4
mmol/l
7.0
7.4
0.29
20
139
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
31
195
1.60
1.69
1.1
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
33
211
1.58
1.68
1.1
1.3
nmol/l
—
0.4
—
0
10
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
284
1.49
1.68
1.6
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
252
1.52
1.66
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
414
3727
1.15
1.65
4.0
3.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
25
2.81
1.65
2.4
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
85
653
1.32
1.64
6.7
7.1
mmol/l
24.7
24.8
0.13
78
603
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
158
1.66
1.62
1.6
1.7
%
65.5
52.3
0.81
15
92
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
14
3.58
1.61
6.0
6.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
5
14
3.58
1.61
1.6
1.4
mmol/l
5.4
4.5
—
5
7
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
28
174
1.62
1.61
1.6
1.4
pmol/l
331.3
308.9
0.14
21
132
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
56
2.15
1.61
1.1
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
56
2.15
1.61
1.1
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
36
238
1.52
1.60
1.1
1.2
u/ml
2.1
4.5
1.14
19
91
(3000764) Benzodiazepines [Presence] in Urine
62
456
1.37
1.60
3.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
61
448
1.38
1.58
4.0
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
297
1.46
1.56
1.6
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
403
3637
1.14
1.55
1.5
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
85
1.89
1.55
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
216
1.54
1.54
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
78
1.93
1.54
1.5
1.4
e6/l
5596.6
114638.0
—
10
42
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
33
2.43
1.54
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
274
1.47
1.52
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
27
169
1.61
1.52
1.7
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
32
209
1.54
1.52
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
93
1.84
1.51
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
49
350
1.41
1.50
1.2
2.2
g/l
0.0
0.0
0.63
43
329
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
86
1.87
1.50
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
242
1.50
1.50
1.2
1.2
u/ml
2.4
1.7
0.38
12
71
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
35
234
1.51
1.50
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
170
1.60
1.49
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
170
1.60
1.49
1.7
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
156
1.61
1.44
1.7
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
16
3.13
1.44
2.0
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
155
1304
1.21
1.42
3.6
3.8
ug/l
3.6
13.2
1.90
121
1020
(3010421) pH of Blood
41
287
1.44
1.42
8.1
3.0
ph
7.4
7.4
1.05
35
228
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
88
1.83
1.41
1.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
205
1.52
1.41
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1435
14058
1.19
1.41
5.3
4.5
mmol/l
2.8
2.9
2.18
1338
13118
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
126
1.68
1.40
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
128
1538
0.82
1.40
1.3
1.3
—
—
—
0
0
(4198724)
10
46
2.18
1.40
5.9
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
46
2.18
1.40
1.5
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
34
230
1.49
1.39
9.0
3.2
mmol/l
2.4
2.8
0.33
26
161
(3013166) Neutrophils/100 leukocytes in Synovial fluid
7
29
2.42
1.39
1.4
1.4
%
31.1
40.7
—
7
22
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
60
451
1.34
1.38
2.4
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
26
166
1.58
1.37
7.1
2.0
%
58.9
61.5
0.24
26
166
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
104
1.74
1.37
2.6
2.4
%
61.2
54.6
0.65
13
67
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
9
41
2.20
1.37
1.0
1.2
pmol/l
197.9
318.1
—
9
31
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
44
315
1.41
1.36
2.0
1.4
e6/l
23.6
12.6
0.28
32
237
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
44
315
1.41
1.36
2.1
1.5
e6/l
351.1
1494.5
0.71
37
253
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
38
266
1.44
1.33
5.1
2.0
—
—
—
0
0
(4306422)
33
225
1.48
1.31
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
217
1.48
1.31
5.1
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1414
13850
1.17
1.30
4.9
4.1
mmol/l
4.8
4.9
1.86
1332
12995
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
24
2.51
1.30
2.3
2.5
umol/l
22.5
20.9
—
6
24
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
34
2.36
1.29
3.8
3.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
396
1.35
1.28
1.3
2.5
g/l
0.3
0.7
0.96
44
353
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
18
2.78
1.28
1.0
1.0
nmol/l
5.7
5.5
—
5
18
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
18
2.78
1.28
1.4
2.0
mmol/l
1.1
1.2
—
5
18
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
45
328
1.38
1.27
1.2
2.3
g/l
0.0
0.0
0.00
40
310
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
57
433
1.33
1.25
1.7
1.6
iu/ml
0.0
0.5
0.57
14
69
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1405
13765
1.16
1.24
4.8
4.1
mmol/l
1.6
1.6
1.76
1309
12853
(1002224) Polysomnography panel
81
646
1.27
1.24
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
139
1.59
1.23
1.5
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
45
330
1.37
1.23
1.2
2.3
g/l
0.0
0.0
0.00
40
311
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
264
0.60
1.22
2.3
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
49
2.05
1.22
1.9
2.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
10
49
2.05
1.22
1.9
2.0
%
8.7
9.5
—
10
49
(3021387) Prolactin [Units/volume] in Serum or Plasma
68
532
1.29
1.21
1.7
1.6
mu/l
287.6
320.4
0.58
59
477
(3043410) Blood group antigens tested for on Red Blood Cells
8
37
2.17
1.21
2.5
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
130
1096
1.20
1.20
2.4
2.4
au/ml
15.9
22.4
—
10
75
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
45
332
1.37
1.19
1.6
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
18
109
1.66
1.19
1.5
1.6
%
32.9
41.0
0.38
12
58
(3010144) Erythrocytes [#/volume] in Synovial fluid
19
117
1.63
1.18
1.5
1.5
e6/l
6895.5
74068.4
0.61
13
75
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
57
1.94
1.17
1.3
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
33
232
1.43
1.15
1.1
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
39
283
1.39
1.15
3.6
3.7
%
57.7
58.4
0.14
39
283
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
175
1.49
1.13
1.7
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
80
1.76
1.13
2.1
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
58
450
1.30
1.12
1.1
1.1
u/ml
31.6
4.7
—
8
69
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
51
1.97
1.11
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
176
1.49
1.10
1.7
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
176
1.49
1.10
1.7
1.3
—
—
—
0
0
(3020891) Body temperature
53
407
1.31
1.10
6.7
4.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
81
1.73
1.09
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
144
1.54
1.09
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
120
1.59
1.08
1.9
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1378
13508
1.14
1.08
5.1
4.2
mmol/l
5.9
5.8
2.80
1279
12488
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
15
89
1.69
1.07
1.5
1.4
u/l
5.1
5.5
—
10
78
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
178
1.47
1.05
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
39
289
1.36
1.03
2.1
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
26
179
1.46
1.03
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
106
1.61
1.03
1.1
1.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
34
2.06
1.03
1.4
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
41
307
1.34
1.02
1.2
3.6
mg/l
41.4
50.5
0.25
33
252
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
196
1.44
1.02
1.4
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
41
308
1.34
1.00
1.2
3.6
mg/l
31.3
37.7
0.25
34
251
(3000093) Morphology [Interpretation] in Blood Narrative
15
91
1.65
1.00
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
35
2.00
1.00
1.0
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
47
361
1.31
1.00
1.2
2.2
g/l
35.7
38.1
1.29
41
322
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
123
1.55
0.99
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
143
1240
1.17
0.99
3.5
2.9
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
29
0.00
0.97
0.0
1.1
—
84.3
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
145
1261
1.16
0.97
1.5
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
149
1.48
0.95
1.7
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
426
1.28
0.95
1.3
2.3
g/l
9.7
10.0
0.19
45
372
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
435
1.27
0.95
1.3
2.3
g/l
3.2
3.1
0.20
43
349
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
109
1.57
0.93
1.6
2.4
u/field
2.9
2.1
—
9
53
(4094501)
45
348
1.30
0.92
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
31
228
1.37
0.89
1.3
3.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
458
1.25
0.88
1.3
2.3
g/l
3.4
3.7
0.77
43
339
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
32
237
1.36
0.88
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
119
1.52
0.88
1.9
1.5
—
—
—
0
0
(4146454)
17
111
1.54
0.87
2.5
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
169
1.43
0.87
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
186
1.40
0.87
3.4
3.4
nmol/l
0.8
0.8
0.16
18
141
(3004451) EKG impression Narrative
8
43
1.86
0.87
1.3
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
459
1.25
0.87
1.3
2.2
g/l
7.6
7.6
0.10
43
359
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
459
1.25
0.87
1.3
2.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
71
587
1.22
0.85
1.4
1.3
miu/ml
217.2
229.6
0.11
31
299
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
72
1.67
0.85
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
80
1.63
0.84
2.5
2.1
%
9.3
10.9
0.81
13
80
(3037556) Urate [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
1.5
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
31
1.94
0.84
1.5
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
45
1.78
0.84
1.5
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
137
1.47
0.84
1.1
1.1
—
—
—
0
0
(44790048)
20
137
1.47
0.84
2.0
1.3
—
—
—
0
0
(44790049)
20
137
1.47
0.84
2.0
1.3
—
—
—
0
0
(44806118)
20
137
1.47
0.84
2.0
1.3
—
—
—
0
0
(44790047)
20
137
1.47
0.84
2.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
178
1591
1.13
0.84
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
146
1.44
0.82
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
46
1.74
0.82
1.6
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
32
1.88
0.82
4.3
5.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
55
445
1.24
0.81
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
175
1566
1.13
0.81
1.8
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
28
207
1.36
0.79
1.2
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
66
1.67
0.78
2.7
2.0
ug/l
30.6
139.0
0.44
11
59
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
25
182
1.38
0.78
1.5
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
23
165
1.40
0.78
1.0
1.1
%
93.8
98.1
0.35
23
158
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
115
1.48
0.77
3.1
3.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
101
874
1.17
0.76
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
19
132
1.44
0.76
2.6
2.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
59
1.70
0.76
1.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
91
1.54
0.75
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
76
643
1.19
0.75
4.1
3.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
115
1007
1.15
0.75
4.6
4.3
%
0.0
0.8
0.86
33
219
(40765089) Chromosome analysis panel - Blood by G-banded
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(44806071)
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
415
1.24
0.74
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
219
0.68
0.73
1.4
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
126
1114
1.14
0.72
4.3
4.1
%
0.8
0.9
0.25
41
284
(3045788) Cell count panel - Pleural fluid
12
76
1.58
0.71
1.7
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
51
417
1.23
0.71
1.2
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
40
1.75
0.71
2.0
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
109
1.47
0.71
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
109
1.47
0.71
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
109
1.47
0.71
1.3
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
301
1.27
0.69
1.1
1.2
u/l
20.2
16.9
0.46
32
235
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
187
1.34
0.68
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
102
1.48
0.67
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
111
1.45
0.66
3.5
3.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
128
1.41
0.65
1.3
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
11
70
1.58
0.65
1.1
1.1
%
87.6
93.0
0.30
11
58
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
62
1.62
0.65
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
84
728
1.16
0.65
2.3
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
144
1296
1.12
0.64
1.2
1.2
iu/ml
158.8
158.9
0.00
45
517
(3021440) Promyelocytes/100 leukocytes in Blood
120
1068
1.13
0.64
4.5
4.2
%
0.1
0.1
1.10
39
259
(3001019) Free T4 and TSH panel - Serum or Plasma
102
1154
0.88
0.63
1.6
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
72
618
1.17
0.63
1.6
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
120
1070
1.13
0.62
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
63
1.59
0.61
2.3
2.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
119
1062
1.13
0.61
1.4
1.3
u/ml
259.9
154.8
0.43
110
987
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
96
1.46
0.61
1.1
1.8
—
—
—
0
0
(44813793)
18
130
1.39
0.61
1.1
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
113
1.42
0.61
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
54
640
0.84
0.61
1.4
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
139
1.37
0.60
2.1
2.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
20
0.00
0.60
0.0
6.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
122
1.40
0.60
3.0
2.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
638
0.84
0.59
1.7
1.8
mg/l
3.1
4.1
0.27
37
451
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
54
1.48
0.57
1.3
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.3
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.3
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
54
1.48
0.57
1.3
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
18
132
1.37
0.57
1.5
2.0
pg
33.1
31.7
0.49
18
132
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
114
1022
1.12
0.56
4.1
3.9
%
0.2
0.7
3.35
28
202
(40760892) CBC W Ordered Manual Differential panel - Blood
345
3261
1.07
0.55
5.2
4.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
32
257
1.25
0.55
1.1
1.1
u/ml
4.7
3.2
0.24
17
129
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
82
1.47
0.54
1.2
1.5
—
—
—
0
0
(4024509)
17
125
1.36
0.53
1.5
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
45
377
1.20
0.53
2.3
2.0
ug/l
1.0
2.1
0.66
39
333
(3009542) Hematocrit [Volume Fraction] of Blood
1309
12909
1.08
0.53
19.0
13.1
%
38.7
39.2
1.60
1001
9831
(3014271) Vancomycin [Susceptibility]
6
39
1.54
0.53
3.0
3.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
30
242
1.24
0.51
1.8
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
65
1.39
0.50
2.2
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
92
1.42
0.50
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
110
0.63
0.48
5.9
6.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
46
1.52
0.48
1.6
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
81
0.62
0.46
1.8
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
33
274
1.21
0.45
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
31
1.61
0.43
3.6
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
124
1139
1.10
0.42
5.4
3.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
56
1.43
0.42
1.8
1.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
12
87
1.38
0.42
1.7
1.3
—
64.4
—
0
10
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
18
140
1.29
0.42
1.8
1.8
%
90.0
90.4
0.16
18
140
(3027923) C peptide [Moles/volume] in Serum or Plasma
10
70
1.43
0.41
1.6
1.6
nmol/l
1.2
1.4
—
10
57
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.41
1.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.41
1.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.41
1.3
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.41
1.3
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
33
1.52
0.41
1.8
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
7.1
—
0
5
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
17
0.00
0.40
0.0
6.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
24
293
0.82
0.40
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
34
287
1.19
0.40
5.4
4.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
150
1.27
0.40
2.6
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
150
1.27
0.40
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.3
—
1.8
—
0
10
(3005033) Fetal Nuchal fold Thickness US
24
292
0.82
0.39
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
52
456
1.15
0.39
2.2
1.9
iu/l
2.9
4.2
1.43
22
177
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
1.1
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
61
1.31
0.39
1.1
1.3
—
—
—
0
0
(4027681)
13
97
1.34
0.39
1.3
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
47
410
1.15
0.38
3.2
3.1
u/ml
40.8
554.0
0.89
37
354
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
135
1.26
0.35
1.4
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
28
330
0.85
0.34
1.3
1.4
nmol/l
0.2
0.3
1.00
22
246
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.33
0.33
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
139
1301
1.07
0.33
1.2
1.3
iu/l
33.6
32.9
0.08
113
1129
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
1.3
2.2
mg/l
7.8
9.3
—
6
37
(3002385) Erythrocyte distribution width [Ratio]
1191
11773
1.04
0.32
22.5
14.7
%
13.7
13.6
0.16
1174
11532
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
52
1.35
0.31
1.0
1.5
ug/l
8.4
8.5
—
7
52
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
184
1.20
0.30
1.7
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
11
84
1.31
0.30
1.0
1.1
—
43.8
—
0
9
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
303
0.86
0.29
1.4
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
26
301
0.86
0.27
1.4
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
120
0.75
0.27
1.1
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
95
1.27
0.26
4.2
1.9
ug/l
31.7
9.6
0.39
12
78
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
132
1.21
0.25
2.1
2.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
74
1.22
0.25
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
96
1.25
0.24
1.0
1.1
u/l
1.0
1.1
—
5
51
(3003740) Influenza virus B Ag [Presence] in Specimen
29
255
1.14
0.24
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
59
543
1.09
0.23
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
256
1.14
0.23
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
91
854
1.07
0.23
1.6
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
97
1.24
0.23
1.6
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1195
12052
0.97
0.22
23.6
15.6
g/l
330.7
330.9
0.22
1185
11975
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
266
1.13
0.22
1.4
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
274
0.87
0.22
1.0
1.1
u/ml
0.0
1.3
—
5
118
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
316
0.88
0.22
1.1
1.1
u/ml
1.0
1.4
—
5
119
(3035880) pH of Pleural fluid
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
36
399
0.90
0.22
4.8
3.7
u/ml
19.5
28.9
1.10
36
385
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
2.1
—
0.0
—
0
5
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
7.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
49.5
—
0
13
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
21
183
1.15
0.20
1.4
1.6
ug/l
3.3
5.3
0.53
14
154
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
49
1.23
0.20
2.0
2.2
nmol/l
162.0
163.6
—
6
43
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
50
1.20
0.19
1.0
3.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
58
1.21
0.18
1.6
2.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
100
1.20
0.18
1.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
35
382
0.91
0.17
1.5
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
25
224
1.12
0.17
2.8
2.6
mmol/l
8.4
7.3
1.24
25
218
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
66
0.76
0.17
1.0
1.1
miu/ml
1410.8
1710.7
—
5
66
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
129
1.16
0.17
1.3
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
67
0.75
0.17
2.4
2.0
ug/l
0.9
3.2
—
5
58
(4281824)
24
215
1.12
0.16
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
69
1.16
0.16
1.1
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
76
0.79
0.15
1.7
1.5
nmol/l
128.5
128.3
—
6
76
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
77
0.78
0.15
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
78
1.15
0.15
1.4
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
79
1.14
0.15
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
254
0.90
0.14
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
33
357
0.92
0.14
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
33
357
0.92
0.14
1.3
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
19
212
0.89
0.14
1.0
1.1
iu/ml
80.7
2592.8
—
6
50
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
103
1.17
0.13
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
33
356
0.93
0.13
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
33
356
0.93
0.13
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
151
1.13
0.13
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
283
0.92
0.12
1.1
1.1
u/ml
4.5
3.5
—
8
136
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
169
0.89
0.12
3.7
5.0
u/ml
9.1
76.6
—
6
51
(3008898) HLA-B27 [Presence]
59
621
0.95
0.12
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
124
1.13
0.11
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
124
1.13
0.11
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
124
1.13
0.11
1.3
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
26
241
1.08
0.10
2.8
2.5
mmol/l
1.6
1.5
0.29
26
233
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
125
1.12
0.10
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
125
1.12
0.10
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
125
1.12
0.10
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
106
1.13
0.09
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
46
1.09
0.09
1.4
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
61
0.82
0.08
2.0
2.3
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
65
0.77
0.08
2.4
2.1
ug/l
1.3
2.6
—
5
55
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
88
1.14
0.08
14.1
11.2
mmol/l
0.7
0.7
—
10
79
(3000012) Reticulocyte production index
7
67
1.04
0.08
1.0
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
15
137
1.10
0.07
1.6
1.4
mosm/kgh2o
280.3
278.1
—
10
103
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
225
0.93
0.07
1.1
1.0
u/ml
0.9
2.7
—
5
75
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
13
118
1.10
0.07
1.0
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
108
1057
1.02
0.06
5.8
3.2
mmol/l
1.2
1.2
0.53
98
913
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
102
0.88
0.06
2.0
1.4
nmol/l
1.5
1.4
—
9
92
(3044927) Protein electrophoresis panel - Urine
10
111
0.90
0.06
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
41
423
0.97
0.04
1.4
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
112
1.07
0.03
2.7
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
249
0.96
0.02
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
138
0.94
0.02
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
48
486
0.99
0.00
1.7
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
272
0.99
0.00
4.1
3.7
mg/l
19.9
22.0
0.17
17
169
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
119
1.01
0.00
1.2
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
20
201
0.99
0.00
1.2
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
207
1.01
0.00
1.7
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
11
105
1.05
0.00
1.6
1.9
nmol/l
18.0
19.3
0.16
11
99
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
79
1.01
0.00
1.3
1.2
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
8
0.00
0.00
0.0
2.1
—
426.9
—
0
8
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
6
68
0.88
0.00
1.5
1.4
%
—
5.5
—
0
16
(3015183) Erythrocyte sedimentation rate
8
84
0.95
0.00
1.5
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
151.2
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
58
0.86
0.00
1.2
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.8
—
373.6
—
0
9
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
72.6
—
0
5
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
89
0.90
0.00
1.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
5.8
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
11.3
—
0
6
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
49
1.02
0.00
1.0
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
8
85
0.94
0.00
2.1
1.8
—
1.2
—
0
7
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
32.8
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint N14_VULVAL_DYSPLASIA_ALL and mortality.

Females

Parameter HR [95% CI] p-value
N14_VULVAL_DYSPLASIA_ALL 1.189 [1.04, 1.36] 0.011
Birth year 0.997 [0.99, 1.01] 0.487

During the follow-up period (1.1.1998 — 31.12.2019), 561 out of 4102 females with N14_VULVAL_DYSPLASIA_ALL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_VULVAL_DYSPLASIA_ALL.

N-year risk Females Males
1 0.119% No data
5 0.789% No data
10 1.98% No data
15 3.774% No data
20 6.424% No data

Relationships between endpoints

↥

Index endpoint: N14_VULVAL_DYSPLASIA_ALL – All dysplastic lesions of the vulva

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data